Quartz·2 min read·medium
Alphabet's Isomorphic Labs raised $5 billion in Series C funding for AI drug design
✦AI Summary
Alphabet's AI-focused subsidiary, Isomorphic Labs, has secured $5 billion in Series C funding. The round was co-led by Greenoaks and Sequoia Capital to accelerate the development of AI-driven drug discovery programs.
Why it matters
This massive investment highlights the growing intersection of generative AI and biotechnology, signaling a major shift in how pharmaceutical research is conducted.
Greenoaks and Sequoia Capital co-led the round as the Alphabet…
Also covering this story
2 other newsrooms covered this event. We read each version separately.
technologybusinessscience
✦
Get smarter about the news
Sign up free for a feed built around what you actually care about, Dive Deeper research on any story, and the full text of every article.
Create free accountAlready have an account? Sign in